Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors

Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors Design and structure–activity relationships of novel inhibitors of human rhinovirus 3C protease Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics VP1 crystal structure-guided exploration and optimization of 4,5-dimethoxybenzene-based inhibitors of rhinovirus 14 infection A model for compounds active against human rhinovirus-14 based on x-ray crystallography data Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication Effect of lipophilicity modulation on inhibition of human rhinovirus capsid binders New anti-viral drugs for the treatment of the common cold Pharmacophore Modeling, Docking, and Principal Component Analysis Based Clustering:  Combined Computer-Assisted Approaches To Identify New Inhibitors of the Human Rhinovirus Coat Protein